Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT₃ receptor antagonist: Results of a phase III, single-dose trial versus dolasetronEISENBERG, Peter; FIGUEROA-VADILLO, Jazmin; ZAMORA, Rosalio et al.Cancer. 2003, Vol 98, Num 11, pp 2473-2482, issn 0008-543X, 10 p.Article

Aprepitant: drug-drug interactions in perspectiveAAPRO, M. S; WALKO, C. M.Annals of oncology. 2010, Vol 21, Num 12, pp 2316-2323, issn 0923-7534, 8 p.Article

Investigation of the association between 5-HT_3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT₃ receptor antagonistsKAISER, Rolf; TREMBLAY, Pierre-Benoit; SEZER, Orhan et al.Pharmacogenetics (London). 2004, Vol 14, Num 5, pp 271-278, issn 0960-314X, 8 p.Article

ONDANSETRON PREVENTS CHANGES IN RESPIRATORY PATTERN PROVOKED BY LICL: A NEW APPROACH FOR STUDYING PRO-EMETIC STATES IN RODENTS?NGAMPRAMUAN, S; BAUMERT, M; CZIPPELOVA, B et al.Neuroscience. 2013, Vol 246, pp 342-350, issn 0306-4522, 9 p.Article

Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting: A Systematic Review and Meta-AnalysisAPFEL, Christian C; KUN ZHANG; KRANKE, Peter et al.Clinical therapeutics. 2010, Vol 32, Num 12, pp 1987-2002, issn 0149-2918, 16 p.Article

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapyHERRSTEDT, Jørn; MUSS, Hyman B; HORGAN, Kevin J et al.Cancer. 2005, Vol 104, Num 7, pp 1548-1555, issn 0008-543X, 8 p.Article

Establishing the dose of the oral NK₁ antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomitingCHAWLA, Sant P; GRUNBERG, Steven M; HORGAN, Kevin J et al.Cancer. 2003, Vol 97, Num 9, pp 2290-2300, issn 0008-543X, 11 p.Article

Pilot investigation of the quantitative EEG and clinical effects of ketazolam and the novel antiemetic nonabine in normal subjectsMCCLELLAND, G. R; SUTTON, J. A.Psychopharmacologia. 1985, Vol 85, Num 3, pp 306-308, issn 0033-3158Article

Essai clinique du plitican dans les vomissements du nourrisson. A propos de quarante cas = Clinical study of plitican in infant vomiting about 40 casesESSOH NOMEL, P; ANDOH, J; OBLAI, S et al.Annales de pédiatrie (Paris). 1985, Vol 32, pp 303-305, issn 0066-2097, 3 bisArticle

PROTEIN BINDING DISPLACEMENT INTERACTIONS AND THEIR CLINICAL IMPORTANCEMCELNAY JC; D'ARCY PF.1983; DRUGS (NEW YORK); ISSN 0012-6667; USA; DA. 1983; VOL. 25; NO 5; PP. 495-513; BIBL. 4 P.Article

Bioequivalence Study of 2 Orodispersible Formulations of Ondansetron 8 mg in Healthy VolunteersCANOVAS, M; RIOS, J; DOMENECH, G et al.Arzneimittel-Forschung. 2012, Vol 62, Num 2, pp 59-62, issn 0004-4172, 4 p.Article

Effectiveness of Palonosetron Versus Other Serotonin 5-HT₃ Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic ChemotherapyKYUNG IM KIM; DONG EUN LEE; CHO, Inhye et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 12, pp 1637-1644, issn 1060-0280, 8 p.Article

Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancerROSCOE, Joseph A; MATTESON, Sara E; MORROW, Gary R et al.Journal of pain and symptom management. 2005, Vol 29, Num 4, pp 376-384, issn 0885-3924, 9 p.Article

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: Results from a randomized, double-blind, placebo-controlled trial in latin americaPOLI-BIGELLI, Sergio; RODRIGUES-PEREIRA, Jose; CARIDES, Alexandra D et al.Cancer. 2003, Vol 97, Num 12, pp 3090-3098, issn 0008-543X, 9 p.Article

RATIONAL USE OF ANOXIOLYTIC/SEDATIVE DRUGSLADER M; PETURSSON H.1983; DRUGS (NEW YORK); ISSN 0012-6667; USA; DA. 1983; VOL. 25; NO 5; PP. 514-528; BIBL. 3 P.Article

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)AAPRO, M; MOLASSIOTIS, A; ROILA, F et al.Annals of oncology. 2012, Vol 23, Num 8, pp 1986-1992, issn 0923-7534, 7 p.Article

Update on anti-emetics for chemotherapy-induced emesisOLVER, I. N.Internal medicine journal (Print). 2005, Vol 35, Num 8, pp 478-481, issn 1444-0903, 4 p.Article

METOCLOPRAMIDE AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USEHARRINGTON RA; HAMILTON CW; BROGDEN RN et al.1983; DRUGS (NEW YORK); ISSN 0012-6667; USA; DA. 1983; VOL. 25; NO 5; PP. 451-494; BIBL. 8 P.Article

The Effect of an Anatomically Classified Procedure on Antiemetic Administration in the Postanesthesia Care UnitRUIZ, Joseph R; KEE, Spencer S; FRENZEL, John C et al.Anesthesia and analgesia. 2010, Vol 110, Num 2, pp 403-409, issn 0003-2999, 7 p.Article

Availability of metoclopramide in vitro and in vivoVERGIN, H; STROBEL, K; GRÄTZ, J. G. V et al.Archiv der Pharmazie (Weinheim). 1984, Vol 317, Num 2, pp 185-188, issn 0365-6233Article

CLINICAL PHARMACOKINETICS OF ACYCLOVIRLASKIN OL.1983; CLINICAL PHARMACOKINETICS; ISSN 0312-5963; AUS; DA. 1983; VOL. 8; NO 3; PP. 187-201; BIBL. 3 P.Article

Progrès récents de la couverture anti-émétique nécessaire en cancérologie = Progress in antiemetic use in cancerologyCUPISSOL, D; SERROU, B.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 36-37, pp 2569-2571, issn 0037-1777Article

Palonosetron Versus Other 5-HT₃ Receptor Antagonists for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer on Chemotherapy in a Hospital Outpatient SettingBALU, Sanjeev; BUCHNER, Deborah; CRAVER, Chris et al.Clinical therapeutics. 2011, Vol 33, Num 4, pp 443-455, issn 0149-2918, 13 p.Article

The Efficacy of Haloperidol in the Management of Nausea and Vomiting in Patients with CancerHARDY, Janet R; O'SHEA, Angela; WHITE, Clare et al.Journal of pain and symptom management. 2010, Vol 40, Num 1, pp 111-116, issn 0885-3924, 6 p.Article

Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy : dosing, efficacy, and tolerability analysisGRUNBERG, S. M.Annals of oncology. 2007, Vol 18, Num 2, pp 233-240, issn 0923-7534, 8 p.Article